MRNA vs RRBI · rev $145.0M vs P/E 12, rev $78.5M
Moderna Inc (MRNA) versus Red River Bancshares Inc (RRBI) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Red River Bancshares Inc (RRBI) is a banks - regional company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported RRBI revenue for 2026-06-30 was $78.5M. Net income was $23.7M. RRBI currently screens at market cap $428.4M and trailing P/E 12.1.
MRNA currently screens at market cap $24.52B. RRBI currently screens at market cap $428.4M and trailing P/E 12.1.
Not investment advice. Open the MRNA and RRBI stock pages for the full models.
Not investment advice.